These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11172843)

  • 1. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome.
    Di Carlo C; Palomba S; Tommaselli GA; Guida M; Di Spiezio Sardo A; Nappi C
    Fertil Steril; 2001 Feb; 75(2):380-4. PubMed ID: 11172843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy.
    Palomba S; Pellicano M; Affinito P; Di Carlo C; Zullo F; Nappi C
    Fertil Steril; 2001 Feb; 75(2):429-33. PubMed ID: 11172852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome.
    Palomba S; Orio F; Manguso F; Russo T; Falbo A; Lombardi G; Doldo P; Zullo F
    Fertil Steril; 2005 Apr; 83(4):1012-20. PubMed ID: 15820814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum leptin levels in patients with premenstrual syndrome treated with GnRH analogues alone and in association with tibolone.
    Tommaselli GA; Di Carlo C; Bifulco G; Di Spiezio Sardo A; Pellicano M; Nappi C
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):716-22. PubMed ID: 14974912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas.
    Palomba S; Orio F; Falbo A; Oppedisano R; Tolino A; Zullo F
    Fertil Steril; 2008 Jul; 90(1):165-73. PubMed ID: 18001721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome.
    Mezrow G; Shoupe D; Spicer D; Lobo R; Leung B; Pike M
    Fertil Steril; 1994 Nov; 62(5):932-7. PubMed ID: 7926137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled cross-over study of effects of tibolone on premenstrual symptoms and peripheral beta-endorphin concentrations in premenstrual syndrome.
    Taskin O; Gökdeniz R; Yalcinoglu A; Buhur A; Burak F; Atmaca R; Ozekici U
    Hum Reprod; 1998 Sep; 13(9):2402-5. PubMed ID: 9806257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata.
    Palomba S; Affinito P; Tommaselli GA; Nappi C
    Fertil Steril; 1998 Jul; 70(1):111-8. PubMed ID: 9660431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
    Freeman EW; Sondheimer SJ; Rickels K
    Psychopharmacol Bull; 1997; 33(2):303-9. PubMed ID: 9230648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis.
    Taskin O; Yalcinoglu AI; Kucuk S; Uryan I; Buhur A; Burak F
    Fertil Steril; 1997 Jan; 67(1):40-5. PubMed ID: 8986681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: effectiveness and effects on vasomotor symptoms, bone mass, and lipid profiles.
    Palomba S; Affinito P; Di Carlo C; Bifulco G; Nappi C
    Fertil Steril; 1999 Nov; 72(5):889-95. PubMed ID: 10560995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial.
    Brown CS; Ling FW; Andersen RN; Farmer RG; Arheart KL
    Obstet Gynecol; 1994 Nov; 84(5):779-86. PubMed ID: 7936512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone metabolism in postmenopausal women who were treated with a gonadotropin-releasing hormone agonist and tibolone.
    Palomba S; Morelli M; Di Carlo C; Noia R; Pellicano M; Zullo F
    Fertil Steril; 2002 Jul; 78(1):63-8. PubMed ID: 12095492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.
    De Falco M; Staibano S; D'Armiento FP; Mascolo M; Salvatore G; Busiello A; Carbone IF; Pollio F; Di Lieto A
    J Soc Gynecol Investig; 2006 May; 13(4):297-303. PubMed ID: 16697947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tibolone on auditory brainstem responses in postmenopausal women--a randomized, double-blind, placebo-controlled trial.
    Sator MO; Franz P; Egarter C; Gruber DM; Wölfl G; Nagele F
    Fertil Steril; 1999 Nov; 72(5):885-8. PubMed ID: 10560994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl).
    Lindsay PC; Shaw RW; Bennink HJ; Kicovic P
    Fertil Steril; 1996 Feb; 65(2):342-8. PubMed ID: 8566259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome.
    Mitwally MF; Gotlieb L; Casper RF
    Menopause; 2002; 9(4):236-41. PubMed ID: 12082359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premenstrual syndrome and related hormonal changes. Long-acting gonadotropin releasing hormone agonist treatment.
    Helvacioglu A; Yeoman RR; Hazelton JM; Aksel S
    J Reprod Med; 1993 Nov; 38(11):864-70. PubMed ID: 8277482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
    Morris EP; Rymer J; Robinson J; Fogelman I
    Fertil Steril; 2008 Feb; 89(2):421-8. PubMed ID: 17572410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: a pilot study.
    Freeman EW; Sondheimer SJ; Rickels K; Albert J
    J Clin Psychiatry; 1993 May; 54(5):192-5. PubMed ID: 8509350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.